Richard Dillon
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 60
- Acute Myeloid Leukemia Research 49
- Chronic Myeloid Leukemia Treatments 17
- Hematopoietic Stem Cell Transplantation 6
- Multiple Myeloma Research and Treatments 5
-
- Retinoids in leukemia and cellular processes 12
- Histone Deacetylase Inhibitors Research 7
- Co-authors
- Nigel H. Russell (31 shared papers)Sylvie Freeman (15 shared papers)Nicola Potter (24 shared papers)Ian Thomas (7 shared papers)Amanda Gilkes (14 shared papers)Kavita Raj (13 shared papers)Alan K. Burnett (6 shared papers)Claire Harrison (13 shared papers)
- Journals
- Blood (26 papers)British Journal of Haematology (9 papers)Blood Advances (6 papers)HemaSphere (5 papers)Leukemia (4 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Richard Dillon
67 papers receiving 816 citations
Peers
Comparison fields: 5 of 63
- Hematology 552
- Genetics 158
- Cancer Research 78
- Immunology 105
- Public Health, Environmental and Occupational Health 129
Countries citing papers authored by Richard Dillon
This map shows the geographic impact of Richard Dillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Dillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Dillon more than expected).
Fields of papers citing papers by Richard Dillon
This network shows the impact of papers produced by Richard Dillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Dillon. The network helps show where Richard Dillon may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard Dillon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 141 | |
| 2 | 2020 | 66 | |
| 3 | 2020 | 49 | |
| 4 | 2022 | 45 | |
| 5 | 2024 | 39 | |
| 6 | 2020 | 31 | |
| 7 | 2021 | 31 | |
| 8 | 2023 | 25 | |
| 9 | 2022 | 21 | |
| 10 | 2024 | 20 | |
| 11 | 2008 | 20 | |
| 12 | 2016 | 19 | |
| 13 | 2023 | 19 | |
| 14 | 2019 | 18 | |
| 15 | 2018 | 17 | |
| 16 | 2021 | 16 | |
| 17 | 2023 | 14 | |
| 18 | 2023 | 14 | |
| 19 | 2024 | 12 | |
| 20 | 2024 | 12 |
About Richard Dillon
Richard Dillon is a scholar working on Hematology, Molecular Biology, Genetics, Public Health, Environmental and Occupational Health and Immunology, having authored 77 papers that have together received 826 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (49 papers), Chronic Myeloid Leukemia Treatments (17 papers), Acute Lymphoblastic Leukemia research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Retinoids in leukemia and cellular processes (12 papers), Histone Deacetylase Inhibitors Research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Multiple Myeloma Research and Treatments (5 papers). The work is most often cited by research in Hematology (552 citations), Genetics (158 citations), Cancer Research (78 citations), Immunology (105 citations) and Public Health, Environmental and Occupational Health (129 citations). Richard Dillon has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Nigel H. Russell, Sylvie Freeman, Nicola Potter, Ian Thomas, Amanda Gilkes, Kavita Raj, Alan K. Burnett, Claire Harrison, David Grimwade and Naeem Khan. Their work appears in journals such as Blood, British Journal of Haematology, Blood Advances, HemaSphere and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.